A Randomized, Double-Blind 4-Week Study to Evaluate the Impact of AXS-05 on Smoking Behavior
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2018
At a glance
- Drugs Bupropion/dextromethorphan (Primary) ; Bupropion
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 23 Apr 2018 According to an Axsome Therapeutics media release, this trial is being conducted under a research collaboration between Duke University and Axsome Therapeutics.
- 23 Apr 2018 According to an Axsome Therapeutics media release, first patient has been enrolled.
- 29 Mar 2018 Status changed from not yet recruiting to recruiting.